DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Antipyrine is an investigational drug.
There have been 5 clinical trials for Antipyrine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2011.
The most common disease conditions in clinical trials are Dysmenorrhea, Turner Syndrome, and Syndrome. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Global United Pharmaceutical Corporation, and Pernix Theraputics LLC.
There are seven hundred and eighty-five US patents protecting this investigational drug and nine international patents.
Recent Clinical Trials for Antipyrine
|Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults||Global United Pharmaceutical Corporation||Phase 2|
|Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media||Pernix Theraputics LLC||Phase 2|
|Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)||Merck Sharp & Dohme Corp.||Phase 3|
Top disease conditions for Antipyrine
Top clinical trial sponsors for Antipyrine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Antipyrine||Start Trial||Heterocyclic compound||Takeda Pharmaceutical Company Limited (Osaka, JP)||Start Trial|
|Antipyrine||Start Trial||Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders||Dana-Farber Cancer Institute, Inc. (Boston, MA)||Start Trial|
|Antipyrine||Start Trial||Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus||Seattle Genetics, Inc. (Bothell, WA)||Start Trial|
|Antipyrine||Start Trial||In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes||XENOTECH LLC (Lenexa, KS)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Antipyrine||European Patent Office||3192791||2034-09-11||Start Trial|
|Antipyrine||World Intellectual Property Organization (WIPO)||2016039408||2034-09-11||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|